Ablynx Competitors and Similar CompaniesClear all
Ablynx's competitors and similar companies include CytomX Therapeutics.
 Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 2001 | Founding Date 2008 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Gent, BE HQ | Locations South San Francisco, US HQ |
Employees | Employees 1252% decrease | Employees 15815% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) $76.2m (FY, 2025) |
Net income | Net income (€1.1m) (FY, 2016) | Net income ($17.4m) (FY, 2025) |
Operating ⚠ | ||
Patents (Foreign) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) 4 (FY, 2016) |
Patents (US) | Patents (US) 50 (Q2, 2017) | Patents (US) 13 (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 132.4m |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company